Carlton Dampier MD
- SOM: Peds: Sickle Cell
Professor
- (404) 727-4510
- cdampie@emory.edu
- Dampier Research
- Children's Healthcare of Atlanta
-
Aflac Cancer & Blood Disorders Center
Emory Children's Center
2015 Uppergate Drive
Academic Appointment
- Professor of Pediatrics, Emory University
Education
Degrees
- MD from University of Chicago
- Graduate Program in Molecular Biology from University of Wisconsin
- BS from Illinois Institute of Technology
Research
Focus
- My research focus has centered on pain assessment and management in children with sickle cell disease (SCD), particularly for that component of care that occurs in the home setting. More broadly, it has become patient-reported outcomes (PRO) as they report on the experience of pain or describe health-related quality of life. Developed instruments are intended for use in both clinical research, practice, and as endpoints for multicenter clinical trials of innovative therapies for SCD
Publications
-
Arginine Therapy for Pain in Sickle Cell Disease: A Phase-2 Randomized, Placebo-Controlled Trial.
Am J Hematol
04/24/2025 Authors: Morris CR; Hatabah D; Korman R; Gillespie S; Bakshi N; Brown LA; Harris F; Leake D; Rees CA; Khemani K -
Moderators of digital cognitive-behavioral therapy for youth with sickle cell disease pain: secondary analysis of a randomized controlled trial.
Pain
03/13/2025 Authors: Palermo TM; Srinakarin K; Zhou C; Lalloo C; Dampier C; Zempsky WT; Badawy SM; Bakshi N; Ko YJ; Nishat F -
Hematopoietic cell transplant compared with standard care in adolescents and young adults with sickle cell disease.
Blood Adv Volume: 9 Page(s): 955 - 965
03/11/2025 Authors: Walters MC; Eapen M; Liu Y; El Rassi F; Waller EK; Levine JE; Strouse JJ; Antin JH; Parikh SH; Bakshi N -
Cobalamin Deficiency in Children and Adolescents with Sickle Cell Disease.
Nutrients Volume: 17
02/06/2025 Authors: Hatabah D; Krieger R; Brown LA; Harris F; Korman R; Reyes L; Umana J; Benedit L; Wynn BA; Rees CA -
What is the future of digital tools to help manage pain in sickle cell disease patients?
Expert Rev Hematol Volume: 17 Page(s): 539 - 541
09/01/2024 Authors: Dampier C -
Impact of arginine therapy on kyotorphin in children with sickle cell disease and vaso-occlusive pain.
Blood Adv Volume: 8 Page(s): 3267 - 3271
06/25/2024 Authors: Korman R; Hatabah D; Brown LA; Harris F; Wilkinson H; Rees CA; Bakshi N; Archer DR; Dampier C; Morris CR -
Opioid Use After First Opioid Prescription in Children With Sickle Cell Disease.
JAMA Pediatr Volume: 178 Page(s): 408 - 410
04/01/2024 Authors: Snyder AB; Zhou M; Attell BK; Cohen LL; Carter S; Bock F; Dampier C -
A cognitive-behavioral digital health intervention for sickle cell disease pain in adolescents: a randomized, controlled, multicenter trial.
Pain Volume: 165 Page(s): 164 - 176
01/01/2024 Authors: Palermo TM; Lalloo C; Zhou C; Dampier C; Zempsky W; Badawy SM; Bakshi N; Ko YJ; Nishat F; Stinson JN -
Patient-reported outcomes in children with sickle cell disease at presentation for an acute pain episode.
Blood Adv Volume: 7 Page(s): 5103 - 5107
09/12/2023 Authors: Bakshi N; Liu Z; Gillespie S; Keesari R; Leake D; Khemani K; Kumari P; Rees CA; Dampier C; Morris CR -
Sickle Cell Disease Treatment with Arginine Therapy (STArT): study protocol for a phase 3 randomized controlled trial.
Trials Volume: 24 Page(s): 538
08/17/2023 Authors: Rees CA; Brousseau DC; Cohen DM; Villella A; Dampier C; Brown K; Campbell A; Chumpitazi CE; Airewele G; Chang T